Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from topical corticosteroids to delgocitinib ointment in adult atopic dermatitis (trunk and limbs)
jRCTs031230102Completed
- Sponsor
- Torii Pharmaceutical
- Start
- Jul 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of budesonide in atopic dermatitis (AD), sponsored by Torii Pharmaceutical. Primary endpoint: Change in patient satisfaction with treatment (TSQM-9). Started Jul 2023; status: completed.
02
Drugs
budesonide
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCTs031230102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230102.